Aging-associated diseases, including cardiac dysfunction, are increasingly common in the 18
Introduction 43
Mitochondria are both the primary source of organismal energy and the major source of cellular 44 reactive oxygen species (ROS) and oxidative stress during aging (1). Aged cardiac 45 mitochondria are functionally changed in redox balance and are deficient in ATP production (2). 46
Numerous reported studies have focused on redox stress and ROS production in aging (1). 47
However, in its simplistic form, the free radical theory of aging has become severely challenged 48
(3). 49
While more attention has been placed on mitochondrial electron leak and consequent free 50 radical generation, proton leak is a highly significant aspect of mitochondrial energetics, as it 51 accounts for more than 20% of oxygen consumption in the liver (4) and 35% to 50% of that in 52 muscle in the resting state (5). There are two types of proton leak in the mitochondria: 1) 53
constitutive, basal proton leak, and 2) inducible, regulated proton leak , including that mediated 54 by uncoupling proteins (UCPs) (6). In skeletal muscle, a majority of basal proton conductance 55
has been attributed to adenine nucleotide translocase (ANT) (7) . Although, aging-related 56 increased mitochondrial proton leak was detected in the mouse heart, kidney and liver by 57
indirect measurement of oxygen consumption in isolated mitochondria (8, 9) , direct evidence of 58 functional impact remains to be further investigated. Moreover, the exact site and underlying 59 mechanisms responsible for aging-related mitochondrial proton leak are unclear. 60 SS-31 (elamipretide), a tetrapeptide (D-Arg-2′,6′-dimethyltyrosine-Lys-Phe-NH2), binds to 61 cardiolipin-containing membranes (10) and improves cristae curvature (11) . Prevention of 62 cytochrome c peroxidase activity and release has been proposed as its major basis of activity 63 (11, 12) . SS-31 is highly effective in increasing resistance to a broad range of diseases, 64
including heart ischemia reperfusion injury (13, 14) , heart failure (15), neurodegenerative 65 disease (16) and metabolic syndrome (17). In aged mice, SS-31 ameliorates kidney 66 glomerulopathy (18) and brain oxidative stress (19) and has shown beneficial effects on skeletal 67 muscle performance (20) . We have recently shown that administration of SS-31 to 24 month old 68 mice for 8 weeks reverses the age-related decline in diastolic function, increasing the E/A from 69 just above 1.0 to 1.22, restoring this parameter 35% towards that of young (5 month old) mice 70 (21) . However how SS-31 benefits and protects aged cardiac cells remains unclear. 71
In this report we investigated the effect and underlying mechanism of action of SS-31 on aged 72 cardiomyocytes, especially on the mitochondrial proton leak. Using the naturally aged rodent 73 model we provided direct evidence of increased proton leak as the primary energetic change in 74 aged mitochondria. We further show that the inner membrane protein ANT1 mediates the 75 augmented proton entry in the old mitochondria. Most significantly, we demonstrate that SS-31 76 prevents the proton entry and rejuvenates mitochondrial function through direct association with 77 ANT1 and stabilization of the ATP synthasome. 78
Results

79
SS-31 alleviates the excessive mitochondrial proton leak in old cardiomyocytes. To 80 examine whether SS-31 restores aging mitochondrial function, we applied the Seahorse 81 mitochondrial stress assay to intact primary cardiomyocytes. The Seahorse Assay revealed 82
higher mitochondrial basal respiration in cells from old mice than that in young mouse cells ( Fig  83  1A, C) ; however, the maximal respiratory rate was not significantly different ( Fig 1A, D) . The 84
increased basal respiration was attributable to a higher proton leak in old cardiomyocytes (165 ± 85 15 in 24 month vs 86 ± 8 in young, pmol/min/800cells, n=11-33, p<0.05) ( Fig. 1A, B ). Acute in 86 vitro treatment of isolated old cardiomyocytes with SS-31 (100 nM, 1 μM, or 10 μM for 2 hrs), 87 caused reduced mitochondrial basal respiration (Fig. 1A , C and Fig. S1 ), shifting their 88 respiratory pattern to a more youthful state. The respiratory control ratio (RCR) was also 89 increased in treated aged cardiomyocytes relative to untreated aged cells ( Fig. 1E ), which was 90 entirely explained by reduced proton leakage ( Fig. 1B) . These results indicate that SS-31 91 directly protects aging cardiac energetics through rapid rejuvenation of mitochondrial respiration 92 in cardiomyocytes, and in particular, by reducing proton leak. 93 SS-31 restores the resistance to external pH gradient stress in old cardiomyocytes. To 94 directly investigate the reduction of mitochondrial proton leak in old cardiomyocytes by SS-31, 95
we expressed the protein mt-cpYFP, a mitochondrial matrix-targeted indicator that was thought 96
to be sensitive to superoxide (22) but turns out to be more sensitive to pH change (23-25) ( Fig.  97 S2). Taking advantage of the pH sensitive character of mt-cpYFP, we developed a novel 98 protocol to evaluate mitochondrial proton leak by exposing mitochondria to a pH gradient stress 99 in saponin permeabilized, mt-cpYFP expressing cardiomyocytes ( Fig. 2A ). The drop in mt-100 cpYFP 488/405 ratio is due to proton leak through the mitochondrial inner membrane into the 101 mitochondrial matrix. To evaluate the physical properties of the mitochondrial inner membrane 102
in the absence of mitochondrial activity, we permeabilized the cardiomyocytes in a buffer that 103 contained no substrates, ATP, or ADP. We found that aging reduced cardiomyocyte 104 mitochondrial resistance to a proton gradient stress ( Fig. 2A ). More importantly, we found 10 μM 105 SS-31 treatment in vitro restored cadiomyocyte mitochondrial inner membrane resistance to the 106 pH gradient stress in the aged cardiomyocytes ( Fig. 2A ). SS-31 treatment largerly prevented the 107 decline in matrix pH of old cells after the external pH was reduced to 5.3 ( Fig. 2B, S3 ) and 108 slowed the rate of cpYFP 488/405 change after pH 6.9 ( Fig. 2C, S4 ). To further evaluate the 109 kinetics of SS-31 effect on mitochondrial proton permeability, we analyzed cpYFP fluorescence 110 ratios at various times after exposure of the saponin treated cardiomyocytes to 10 μM SS-31.
111
SS-31 protection of on the mitochndrial matrix proton entry became significant and near 112 maximal after 7-10 minutes of SS-31 treatment ( Fig. 2D ). We examined the dose effect of SS-113 31 on proton permeability and found near-maximal effects at 100 nM SS-31 ( Fig. 2E ). In 114 summary, this is the first direct evidence that aging increases mitochondrial inner membrane 115 proton permeability in aged cardiomyocytes and that SS-31 protects cardiomyocytes from this 116 proton leak. 117 ANT1 inhibitors restore resistance of old cardiomyocytes to proton leak. In search of the 118 source of the uncoupled proton leak in the aged cells, we examined possible involvement of 119 proton leakage through ATPase and mitochondrial uncoupling proteins (UCPs). The ATPase 120
inhibitor Oligomycin A failed to inhibit the proton leak in pH challenged permeabilized aged cells 121 (Fig. 3A, B ). Levels of UCP2, which is the dominant isoform of UCPs in the heart, do not change 122 with in age in hearts ( Fig. S5 ). Genipin, an inhibitor of UCP2, showed no effect on the proton 123 leak in permeabilized aged cells ( Fig 3A, B) . These results suggest that the ATPase and UCP2 124 may not be the source of the excess proton leak in the aged hearts. 125
Recently, the inner membrane protein ANT1 (also called AAC) was identified as the major site 126 of proton leak in mitochondria of multiple tissues (26), and was shown to contribute to the 127 majority of the proton leak in muscle cells (7) . Treatment of old cardiomyocytes with either the 128 ANT1 inhibitor bongkrekic acid (BKA) (27) or carboxyatractyloside (CAT) (28) completely 129
suppressed the excess proton leak in the Seahorse assay, though unlike SS-31, they also 130 decreased the maximal respiratory rate and failed to enhance the RCR ( Fig 1B, C, E), which is 131
consistent with the effect seen in the ANT triple knockout model (29). We treated permeabilized 132 old cardiomyocytes with the ANT1 inhibitors and examined the mt-cpYFP response to an 133 external pH gradient using the protocol described above. BKA suppressed the proton leak in old 134 cardiomyocytes, evidenced by the preserved 488/405 ratio at pH 5.3 and a slower 488/405 ratio 135 decrease at pH 6.9 (Fig. 3A, B ). Similar inhibition was found with CAT treatment (Fig. 3A, B) . 136
Taken together, these data implicate ANT1 as the major site of proton leak in aging hearts. 137
SS-31 attenuates the excessive mitochondrial flash (mitoflash) activity of aged 138
cardiomyocytes, while normalizing membrane potential and ROS. The mitoflash (22, 30-139 34) , is triggered by nanodomain proton influx into the mitochondrial matrix (35). Thus, we 140 wondered whether the increased proton leak in the old cells triggered excessive mitoflash 141 activity. We evaluated mitoflash activity in isolated young and old rat cardiomyocytes using the 142
indicator mt-cpYFP, as established in the previous studies noted above. The mitochondrial 143 mitoflash activity in the cells from old (26 mo) cardiomyocytes was higher than that of young (5 144 mo) cells (2.8 ± 0.3 in old vs 1.4 ± 0.2, /1000μm 2 /100s in young cells, n=28-88, p<0.05).
145
Confirming this, we detected an increase in mitoflash activity in Langendorff perfused intact 146
aged hearts from mt-cpYFP transgenic mice ( Fig. S6 ). 1 hour treatment with SS-31 normalized 147 the mitoflash activity in old cells to the young cell level ( Fig. 4D ). Moreover, the mitochondrial 148 ANT1 inhibitors BKA and CAT showed super-suppression of the flash activity, reducing this 149 frequency to half of that of young cells (Fig. 4D ). These data support the notion that proton leak 150 from ANT1 triggers the mitoflash in cardiomyocytes and is responsible for the excess mitoflash 151 activity of old cells. Moreover, the mitochondrial membrane potential, which is lower in old 152 cardiomyocytes, is restored to youthful levels by SS-31 treatment ( Fig. 4E ). Also, SS-31 153 reduced ROS production in the aged cardiomyocytes ( Fig. 4F ). Thus, the reduction of 154 mitochondrial proton leak by SS-31 is accompanied by a more youthful membrane potential and 155 dynamic function (mitoflash), as well as less oxidative stress. 156
SS-31 reverses increased mPTP opening in aged cardiomyocytes. Due to the close link 157
previously established between the mitoflash and mitochondrial permeability transition pore 158 (mPTP) opening (33), we evaluated mPTP activity by the photon-triggered mPTP opening 159 protocol ( Fig. 5A ) (36). Consistent with previous reports in isolated mitochondria (37), we found 160 that the time to mPTP opening is decreased in intact old cardiomyocytes ( Fig. 5B ). SS-31 and 161 the ANT1 inhibitor BKA, which stabilizes the ANT1 in the m-state open towards the 162 mitochondrial matrix, both protect the aging-increased mitochondrial mPTP opening rate ( Fig.  163 5B), consistent with previous observations that BKA prevents the onset of the permeability 164 transition (38). The ANT1 inhibitor CAT, which stabilizes ANT1 in the c-state open toward the 165 cytosol, failed to prevent the rapid opening of the mPTP in old cells ( Fig. 5B ), consistent with 166 previous observations that it facilitates mPTP opening (38), These data indicate that SS-31 167 decreases mPTP opening in old cardiomyocytes. 168 SS-31 associates directly with ANT1 and the ATP synthasome. To further investigate the 169 mechanism of SS-31 protection of the proton leak, we used biotinylated SS-31 to evaluate 170
whether SS-31 directly interacts with the ANT1 protein. Hearts were disrupted by douncing, 171
after a low speed spin to remove fragments, mitochondria were collected by high speed spin 172
and disrupted in digitonin, to create lipid rafts containing their associated proteins, a protocol 173 commonly used to prepare mitochondrial supercomplexes (39). This preparation was incubated 174
with SS-31-biotin or biotin only, followed by incubation with streptavidin beads. After washing, 175
the bead-bound fraction was eluted with excess SS-31 and analyzed by Western blotting. 176
Biotin-SS-31 pulled down ANT1, and free SS-31 competed with the biotin-SS-31 binding to 177 ANT1 ( Fig. 6A, B ). Most notably, both BKA and CAT inhibited binding of biotin-SS-31 to ANT1 178 ( Fig. 6A, B ). This competition was observed even at BKA and CAT concentrations in the tens of 179 namomolar range, which is similar to their reported Kd of binding to ANT1 (40) (data not 180 shown). Biotin-SS-31 pulldown of ANT1 was not inhibited by Genipin or Oligomycin A ( Fig. 6A,  181 B). These data indicate that SS-31 associates closely with the ANT1 protein. Moreover, native 182 gel and ATPase blot analysis showed that SS-31 stabilized the ATP synthasome, of which 183 ANT1 and ATPase are critical members (41) (Fig. 6D , E and S7). However, SS-31 treatment did 184 not produce a detectable increase in mitochondrial complex proteins by Coomassie blue 185 staining ( Fig. 6C ). Taken together, these data suggest that SS-31 interacts directly with ANT1 186
and stabilizes the ATP synthasome in old cardiomyocytes. 187
Discussion:
188
In this report we have shown direct evidence of increased proton leak in the aged mitochondria 189
as a primary energetic disturbance and evidence that the increased proton entry in old 190 cardiomyocytes takes place through ANT1. Moreover, we demonstrated that SS-31 prevents 191
the proton entry to the mitochondrial matrix and rejuvenates mitochondrial function through 192 direct interaction with ANT1 and stabilization of the ATP synthasome. During aging, the 193 pathological augmented and sustained basal proton leak burdens the mitochondrial work load, 194
resulting in a decline in respiratory efficiency. Blocking this pathological proton leak induced by 195
aging benefits the mitochondria and the heart (Fig. 7) . We suggest that the restoration of aged 196 mitochondrial function that is conferred by SS-31 is directly attributable to this effect. However, 197
the resulting enhancement in diastolic function is likely to require downstream changes, as the 198 functional benefit took up to 8 weeks to reach full effect, and required post-translational 199 modifications of contractile protein elements (21). It is increasingly recognized that mitochondrial 200 function, including redox status and energetics, has far-reaching effects, including epigenetic 201
alterations and post-translational modifications (42). 202 ANT1 appears to mediate the pathological mitochondrial proton leak in the aged mouse heart. 203
Although an increased mitochondrial proton leak in the aged heart was previously suggested by 204
indirect oxygen consumption measurement (9), the site of this augmented proton leak in aging 205 mitochondria has remained a puzzle. We directly evaluated the proton leak using the 206 mitochondrial matrix targeted pH indicator (mt-cpYFP) and provide evidence that implicates 207 ANT1, the ATP/ADP translocator, as responsible for the pathologically increased proton leak in 208 aged cardiomyocytes. This does not necessarily implicate the ADP/ATP translocase mechanism 209 itself in the proton leak, as in the unenergetic state in which we examined the mitochondrial pH 210
resistance, there would be no ADP/ATP transport activity. Our result is, however, supported by 211 a recent report that proton transport is an integral function of ANT1 (26). Because the ANT1 212 protein level is not increased in the aged heart (it is, in fact, mildly but significantly decreased, 213 Fig. S5 ), the aging-augmented proton leak through ANT1 must be through altered transport 214 activity or conformational change. Both the inhibitors of BKA (locking ANT1 in m-state (27)) and 215
CAT (locking ANT1 in c-state (28)) suppressed the proton leak in the aged cardiomyocytes, 216
suggesting that constraining the conformational state in either position, or otherwise blocking 217 the proton pore reduces ANT1 proton translocation. 218
Most interestingly, for the first time, we showed that a novel drug, SS-31 (elamipretide), now in 219 clinical trials, prevents the augmented mitochondrial proton leak, rejuvenates mitochondria 220 function and reverses aging-related cardiac dysfunction. Mechanistically, we found that SS-31 221 directly interacts with ANT1 and stabilizes formation of the ATP synthasome. This would seem 222 surprising, given the prior belief that SS-31 affects mitochondria via binding to cardiolipin. 223
However, the notion that SS-31 prevents the proton leak by direct interaction at the pore 224
"pocket" of ANT1 is supported by recent observations based on cross-linking "interactome" 225 mass-spectroscopy that showed that SS-31 is in intimate proximity to two lysine amino acid 226 residues in the water filled cavity of the ANT1 protein (43). Moreover, the cross-linking data 227
suggested that this interaction may have structural consequences and may stabilize the m-state 228 of ANT1. Our observation that both BKA and CAT blocked the SS-31 interaction with ANT1 229
suggests that SS-31 interacts with ANT1 independent of the ANT1 face to m-state (matrix 230 facing) or c-state (cytoplasmic-facing). It has recently been shown that SS-31 alters surface 231 electrostatic properties of the mitochondrial inner membrane (44). The consequences of this 232 effect could include alteration of the channel ion gating properties of the ANT and/or promotion 233 of supercomplex and ATP synthasome complex stability. Thus, we do not wish to convey the 234 impression that SS-31 effects only ANT1, as this is certainly not the case (Supplemental Figure  235 8, and reference (43)). Stabilization of mitochondrial supercomplexes and the synthasome could 236 directly contribute to the enhanced mitochondrial respiratory efficiency that is seen in muscle of 237 SS-31 treated old animals (20) and the improvement in performance of humans with primary 238 mitochondrial myopathy (45) that forms the basis of an ongoing Phase III Clinical trial 239
(NCT03323749). 240
The restoration of membrane potential by SS-31 the old mitochondria ( Fig. 4E) can be attributed 241
to the suppression of proton leak. However, SS-31 also decreased ROS production ( Fig. 4F ) in 242 the aged cardiomyocytes. It is unclear if the reduced ROS production is associated with 243 modification of the ANT1 shown here or through a parallel mechanism. Blocking this 244 pathological proton leak induced by aging will benefit the mitochondria and the heart. This is not 245
in conflict with the "uncoupling to survive hypothesis", which arises from the positive correlations 246
between increase proton leak, reduced ROS and increased lifespan (46). This reduced ROS 247 production is interpreted as resulting from decreased electromotive force and consequent 248
reduced electron leak during transport through the respiratory chain. However, SS-31 through 249
its interaction with cardiolipin, abundant in the inner membrane, can improve the efficiency of 250 electron transfer, especially by its known interaction with the heme group of cytochrome c (11, 251 12), thereby reducing ROS production, even as the aged mitochondrial membrane potential is 252 increased. Thus, our data support the conclusion that SS-31 interaction with multiple inner 253 membrane proteins enhances the performance of multiple facets of respiratory mechanics. 254
In summary, our study reveals that ANT1 is responsible for the elevated proton leak in old 255
cardiomyocytes and that SS-31 directly interacts with ANT1, preventing the proton leak and 256
rejuvenating mitochondrial function in the aged cardiomyocytes. The improved mitochondrial 257 function leads to complex secondary changes to effect enhanced diastolic function in the aged 258
heart. These findings provide a novel insight for better understanding of the mechanisms of 259 cardiac aging and establish the novel concept that decreasing the pathological proton leak in 260 the aging heart restores mitochondrial function, ultimately reversing cardiac dysfunction in 261
aging. 262
Methods: 263
Animals. All the animal procedures were approved by the Institutional Animal Care and Use 264
Committee at the University of Washington and conform to the NIH guidelines (Guide for the 265 care and use of laboratory animals). Young (4-6 month-old) and aged (24-26 month-old) 266 C57BL/6 mice (Charles River colony) and F344 rats were obtained from the National Institute of 267
Aging Rodent Resource. The mt-cpYFP transgenic C57BL/6 mice were housed until reaching 268 the age described. 269
Isolation of adult mouse and rat cardiomyocytes. Single ventricular myocytes were 270 enzymatically isolated from mouse and rat hearts as described previously (47, 48 mitochondrial flashes, mt-cpYFP expressing cells were exposed to alternating excitation at 405 284 and 488 nm and emission collected at >505 nm. Time-lapse 2D images were collected at a rate 285 of 1 s per frame. For mitochondrial superoxide quantitation, we used the ratio of MitoSOX Red 286
(5 μM, excited at 540 nm with emission collected at > 560 nm) to mitoTracker Green (200 nM, 287 excited at 488 nm and emission collected at 505-530 nm). For mitochondrial membrane 288 potential measurement, JC-1 was excited at 488 nm and emission collected at 510-545 nm and 289 570-650 nm. For photon triggered mPTP opening, the cells were loaded with 120 nM 290
Tetramethylrhodamine methyl ester (TMRM) and line scanned at 1 Hz as described previously 291 (36). 292
Cell permeabilization and pH stress. Rat cardiomyocytes were cultured with mt-cpYFP 293 adenovirus (34) for 3 days in M199 medium. After incubation in Ca 2+ -free Tyrode's solution for 294 30 min, the medium was changed to a solution of 100 mM potassium aspartate, 20 mM KCl, 10 295 mM glutathione, 10 mM KH 2 PO 4 , 0.1 mM EGTA, 8% dextran 40,000, pH 7.5, with 50 μg/ml 296 saponin for 30 s and then maintained in saponin-free internal solution (49). The pH of the 297 solution containing the permeabilized cells was then progressively lowered by addition of HCl in 298
quantities previously titrated to result in pH 7.3, 6.9, 5.3, and 4.5, with 8 min between each step. 299
The permeabilized cells were excited using same settings as for mt-cpYFP above, but using a 300 time-lapse of 6 s per frame. The ratio of emission fluorescence at 488 nm from 405 nm 301 excitation indicated the mitochondrial pH change (23) and was normalized to a starting (pH 7.5) 302
arbitrary value of 1.0, so as to normalize differences due to variability of the intensity of laser 303 excitation and emission collection between different experiments. 304
Western blots. Heart tissue was lysed with RIPA buffer containing a protease inhibitor cocktail 305 (50). Protein samples were denatured and separated via NuPAGE Bis-Tris gel, and transferred 306
to PVDF membranes. The blots were probed with primary antibodies: ANT1 (Abcam, ab102032, 1:3000), UCP2 (Cell signaling technology, 89326S, 1:2000) followed by appropriate secondary 308
antibodies. 309
Biotin-SS-31 pulldown and Blot Analysis. Hearts were chunked and dounce homogenized in 310 mitochondrial isolation buffer (MIB, in mM: 300 sucrose, 10 Na-HEPES, 0.200 EDTA, pH 7.4) 311
and centrifuged at 800 g for 10 min. The supernatants were centrifuged at 8000 g for 15 min to 312 purify mitochondria. Digitonin was added to the mitochondria at a ratio of Digitonin : protein = 6 313
:1 to break down the membrane system. Treatment drugs were added 30 min before addition of 314 10 μM biotin-SS-31 (Biotin-D-Arg-dimethyl Tyr-Lys-Phe-NH2) or biotin control (Thermo, 315 B20656). Streptavidin Agarose beads (Thermo, 20349) were added and incubated 2 hr at room 316 temperature. The beads were washed with MIB 3 times and then eluted by 50 μM SS-31. The 317
eluates were boiled with LDS protein loading buffer (Thermo, NP0008) and loaded on NuPAGE 318
for gel electrophoresis and Western blotting with antibody to ANT1 (Abcam, ab102032, 1:3000).
319
In some experiments, after electrophoresis, gels were silver stained using a Pierce Silver Stain 320
Kit (Thermo, #24612). 321 Native coomassie blue staining and blotting. Mitochondria from mouse hearts were isolated 322
as described previously (51) imaging, the left ventricle was gently pressed to further suppress motion artifact. Mitoflashes 338
were imaged using the procedure described above. 339
Data statistics. 340
Data are shown as mean ± SEM. One-way ANOVA was used for experiments with more than 2 341 groups, followed by Tukey's post hoc analysis. P < 0.05 was considered statistically significant. 342 343 young and old mice, then exposed or not to 100nM SS-31 for 2 hr in vitro. Aging increased 360
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basal respiration (C), which was attributable to the augmentation of proton leak (B), but did not cardiomyocytes expressing mt-cpYFP were exposed to progressively lower external pH. Proton 369 permeability of old mitochondria was greater than that of young mitochondria, but preincubation 370 of old cells with 10 μM SS-31 for 3 days enhanced the mitochondrial inner membrane resistance 371
to the pH stress. The arrows indicate the changes of pH. (B) Quantitation of the SS-31 372 treatment effect on the mitochondrial matrix cpYFP ratio at pH 5.3. The data are from 7-8 min 373
after the pH was adjusted to 5.3. (C) SS-31 decreased the rate of cpYFP 488/405 ratio drop at 374 pH 6.9. The rate is calculated as indicated in Supplemental Figure 4 . The time dependence (D) 375
and dose dependence (E) of SS-31 protection of mitochondrial resistance to pH gradient stress 376 are shown. After cardiomyocyte permeabilization, 10 μM SS-31 was added for the times shown 377 in (D) or at the doses shown in (E) for 30 minutes, followed by pH stress. N=4 -18 in each 378 group *: P < 0.05 vs Young, #: P < 0.05 vs Old. 379 380 Fig. 3 : ANT1 inhibitors restore resistance to proton leak in old cardiomyocytes. ANT1 inhibitors 381
10 μM BKA and 20 μM CAT, but not 50 μM Genipin (UCP2 inhibitor) or 1 μM OA (ATPase 382 inhibitor), protected the mitochondrial matrix from decreased pH after exposure to external pH 383 5.3 (A) and reduced the rate of 488/405 decline after exposure to pH 6.9 (B). BKA, CAT, 384
Genipin, or OA were added immediately after the mitochondria permeabilization. N=4-14 in 385 each group *P < 0.05 vs Young, #P < 0.05 vs Old. to that of the value at pH=7.5) as the pH is gradually lowered. The ratio of 488/405 reaches the 427 lowest point at pH 6.0, followed by a small increase starting at pH 5.5, consistent with the known 428 pH response of this dye (23). (B) shows the emission spectra of mt-cpYFP pH 8.0, 6.0 and 4.5 429 when excited at 488 nM (C) shows the emission spectra of mt-cpYFP pH 8.0, 6.0 and 4.5 when 430 excited at 405nm. The 488 nm excitation is sensitive to the pH change but the 405 nm excitation 431
is much less pH dependent. after permeabilized cells are exposed to external pH 6.9. The trace is from old cardiomyocytes. 
